141 related articles for article (PubMed ID: 36336070)
21. Sperm Release From the Oviductal Epithelium Depends on Ca(2+) Influx Upon Activation of CB1 and TRPV1 by Anandamide.
Gervasi MG; Osycka-Salut C; Sanchez T; Alonso CA; Llados C; Castellano L; Franchi AM; Villalón M; Perez-Martinez S
J Cell Biochem; 2016 Feb; 117(2):320-33. PubMed ID: 26129689
[TBL] [Abstract][Full Text] [Related]
22. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
[TBL] [Abstract][Full Text] [Related]
23. Hippocampal endocannabinoids play an important role in induction of long-term potentiation and regulation of contextual fear memory formation.
Lin QS; Yang Q; Liu DD; Sun Z; Dang H; Liang J; Wang YX; Chen J; Li ST
Brain Res Bull; 2011 Oct; 86(3-4):139-45. PubMed ID: 21801815
[TBL] [Abstract][Full Text] [Related]
24. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.
Lisboa SF; Guimarães FS
Neuropharmacology; 2012 Jun; 62(8):2455-62. PubMed ID: 22394688
[TBL] [Abstract][Full Text] [Related]
25. Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat.
Hong S; Fan J; Kemmerer ES; Evans S; Li Y; Wiley JW
Gut; 2009 Feb; 58(2):202-10. PubMed ID: 18936104
[TBL] [Abstract][Full Text] [Related]
26. High fat diet induced obesity alters endocannabinoid and ghrelin mediated regulation of components of the endocannabinoid system in nodose ganglia.
Christie S; O'Rielly R; Li H; Wittert GA; Page AJ
Peptides; 2020 Sep; 131():170371. PubMed ID: 32659299
[TBL] [Abstract][Full Text] [Related]
27. Endocannabinoid modulation of fear responses: learning and state-dependent performance effects.
Reich CG; Mohammadi MH; Alger BE
J Psychopharmacol; 2008 Sep; 22(7):769-77. PubMed ID: 18308796
[TBL] [Abstract][Full Text] [Related]
28. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
[TBL] [Abstract][Full Text] [Related]
29. Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state.
Rea K; Ford GK; Olango WM; Harhen B; Roche M; Finn DP
Eur J Neurosci; 2014 Feb; 39(3):435-43. PubMed ID: 24494683
[TBL] [Abstract][Full Text] [Related]
30. Dorsal hippocampus cannabinoid type 1 receptors modulate the expression of contextual fear conditioning in rats: Involvement of local glutamatergic/nitrergic and GABAergic neurotransmissions.
Spiacci GB; Antero LS; Reis DG; Lisboa SF; Resstel LB
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1579-89. PubMed ID: 27591981
[TBL] [Abstract][Full Text] [Related]
31. CB
Medeiros P; Oliveira-Silva M; Negrini-Ferrari SE; Medeiros AC; Elias-Filho DH; Coimbra NC; de Freitas RL
Brain Res Bull; 2020 Dec; 165():118-128. PubMed ID: 33038420
[TBL] [Abstract][Full Text] [Related]
32. Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy.
Bhaskaran MD; Smith BN
Exp Neurol; 2010 Jun; 223(2):529-36. PubMed ID: 20144892
[TBL] [Abstract][Full Text] [Related]
33. CB
Dos Anjos-Garcia T; Ullah F; Falconi-Sobrinho LL; Coimbra NC
Neuropharmacology; 2017 Feb; 113(Pt A):156-166. PubMed ID: 27062913
[TBL] [Abstract][Full Text] [Related]
34. Periaqueductal gray glutamatergic, cannabinoid and vanilloid receptor interplay in defensive behavior and aversive memory formation.
Back FP; Carobrez AP
Neuropharmacology; 2018 Jun; 135():399-411. PubMed ID: 29596901
[TBL] [Abstract][Full Text] [Related]
35. The role of the cannabinoid system in fear memory and extinction in male and female mice.
Mizuno I; Matsuda S; Tohyama S; Mizutani A
Psychoneuroendocrinology; 2022 Apr; 138():105688. PubMed ID: 35176534
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB
Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131
[TBL] [Abstract][Full Text] [Related]
37. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
[TBL] [Abstract][Full Text] [Related]
38. The interactive role of cannabinoid and vanilloid systems in hippocampal synaptic plasticity in rats.
Tahmasebi L; Komaki A; Karamian R; Shahidi S; Sarihi A; Salehi I; Nikkhah A
Eur J Pharmacol; 2015 Jun; 757():68-73. PubMed ID: 25843413
[TBL] [Abstract][Full Text] [Related]
39. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.
Domenicali M; Ros J; Fernández-Varo G; Cejudo-Martín P; Crespo M; Morales-Ruiz M; Briones AM; Campistol JM; Arroyo V; Vila E; Rodés J; Jiménez W
Gut; 2005 Apr; 54(4):522-7. PubMed ID: 15753538
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo.
Jacob W; Marsch R; Marsicano G; Lutz B; Wotjak CT
Neurobiol Learn Mem; 2012 Jul; 98(1):47-55. PubMed ID: 22579951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
